Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.92
+$0.06 (+0.47%)
Nov 2, 2026, 10:05 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
PE Ratio | -20.63 |
PEG Ratio | n/a |
PS Ratio | n/a |
PB Ratio | -8.60 |
P/FCF Ratio | -25.08 |
P/OCF Ratio | -25.51 |
OCF/S Ratio | n/a |
Debt / Equity Ratio | -0.03 |
Quick Ratio | 12.01 |
Current Ratio | 12.01 |
Asset Turnover | n/a |
Interest Coverage | n/a |
Return on Equity | 41.79% |
Return on Assets | -21.52% |
Return on Invested Capital | -24.48% |
Dividend Yield | n/a |
Payout Ratio | n/a |
FCF Payout Ratio | n/a |
Gross Profit Margin | n/a |
Net Profit Margin | n/a |
Pretax Profit Margin | n/a |
Operating Profit Margin | n/a |
FCF Margin | n/a |
EBITDA Margin | n/a |
Add to Watchlist
Select watchlists to add or remove KLRA